Have questions? Visit https://www.reddit.com/r/SNPedia

rs80338726(A;A)

From SNPedia
(Redirected from Rs80338726(AC;AC))

Citrullinemia type II/citrin deficiency; neonatal and/or adult-onset
Is agenotype
ofrs80338726
GeneSLC25A13
Chromosome7
Position96,121,696
mentionedby
Magnitude5.7
ReputeBad
Geno Mag Summary
(-;-) 0 common in clinvar
(-;A) 3 Carrier of a citrullinemia/citrin deficiency allele
(A;A) 5.7 Citrullinemia type II/citrin deficiency; neonatal and/or adult-onset

Pathogenic in ClinVar;see sidebar on main SNP page. This is a genotype with recommended actions if clinically confirmed. In brief:

  • CTLN2 can appear suddenly in children or adults as recurrent hyperammonemia with neuropsychiatric symptoms.
  • To prevent hyperammonemia a diet rich in protein and lipids and low in carbohydrates is recommended. Diet composition consultation and a medical genetics consultation are recommended. However, the effectiveness of dietary treatment prior to the onset of symptoms of CTLN2 is unknown.
  • Alcohol, acetaminophen and rabeprozole may trigger CTNL2.
  • Arginine and sodium pyruvate administration may be effective in preventing hyperammonemic crises (by reducing blood ammonia concentrations) and fatty liver, thereby delaying the need for liver transplantation.
  • Liver transplantation is the most successful therapy to date for symptomatic patients. More recently, some reports indicate that arginine and sodium pyruvate administration combined with a carbohydrate-restricted diet may be an effective therapy.
  • Should severe brain edema occur, avoid treatment with glycerol-containing osmotic agents.
  • Determining the genetic status of at-risk relatives could allow an infant's diet to be managed for citrin deficiency before symptoms occur.


The full ClinGen Actionability report about adult-onset type II citrullinemia (CTLN2) can be found here.

Genetic counseling may be available to you through your health-care network. Additional information is available via our Find A Genetic Counselor webpage, located here.